|
Srinivas Akkaraju, M.D., Ph.D., has served as a Director of Seattle Genetics since July 2003. Dr. Akkaraju is a Managing Director at Panorama Capital. Previously, he was with J.P. Morgan Partners, serving as a Principal starting in April 2001 and becoming a Partner in January 2005. From October 1998 to April 2001, he was in Business and Corporate Development at Genentech, Inc., most recently as Senior Manager. Prior to joining Genentech, Dr. Akkaraju was a graduate student at Stanford University, where he earned his M.D. and a Ph.D. in Immunology. He received his undergraduate degrees in Biochemistry and Computer Science from Rice University. He is also a director of Barrier Therapeutics.
| 